M&A Deal Summary

SGS Acquires Aster-Cephac SA

On January 5, 2006, SGS acquired life science company Aster-Cephac SA from CAI Capital Partners and EEP Advisers

Acquisition Highlights
  • This is SGS’s 1st transaction in the Life Science sector.
  • This is SGS’s 1st transaction in France.

M&A Deal Summary

Date 2006-01-05
Target Aster-Cephac SA
Sector Life Science
Buyer(s) SGS
Sellers(s) CAI Capital Partners
EEP Advisers
Deal Type Add-on Acquisition

Target

Aster-Cephac SA

Paris, France
Aster-Cephac, based in Paris, France, was a contract research organization specializing in providing clinical pharmacology and bioanalytical services to the international pharmaceutical, biotechnology and medical device industries. Aster-Cephac enabled its clients to maximize the profitability of products during the period of exclusivity by offering high-quality, value-added services designed to reduce drug development time.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

SGS

Geneva, Switzerland

Category Company
Founded 1878
Sector Test/Measurement Equipment
Employees94,938
Revenue 6.8B CHF (2024)
DESCRIPTION
Entrance to SGS' headquarters in Geneva, Switzerland.
Entrance to SGS' headquarters in Geneva, Switzerland.

SGS provides testing, inspection, and certification services for industries including agriculture, chemicals, consumer goods, energy, and transportation. The Company supports clients in verifying product quality, meeting regulatory standards, and ensuring supply chain integrity. SGS was founded in 1878 and is based in Geneva, Switzerland.


DEAL STATS #
Overall 1 of 52
Sector: Life Science M&A 1 of 6
Type: Add-on Acquisition M&A Deals 1 of 44
Country: France M&A 1 of 2
Year: 2006 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-12-10 FTS Inspection & Engineering Services Inc

Bartlesville, Oklahoma, United States

Buy -

Seller(S) 2

SELLER

CAI Capital Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1989
PE ASSETS 1.6B CAD
Size Large
Type Sector Agnostic
DESCRIPTION

CAI Capital Partners is a private equity firm that targets lower middle-market, profitable companies with $3 million or more of EBITDA. CAI Capital Partners has a special interest in founder-led business services or specialty manufacturing companies. CAI Capital Partners was formed in 1989 and is based in Vancouver, British Columbia.


DEAL STATS #
Overall 8 of 22
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 6 of 14
Country: France M&A 1 of 1
Year: 2006 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-11-01 Plastube

Granby, Quebec, Canada

Plastube is an established leader in the manufacture and decoration of plastic mono-layer and PolyFoil® (barrier) tubes, predominantly for large personal care and cosmetics companies. Plastube has a strong niche position in short run, highly decorative tube manufacturing and has a strong loyal customer base that continues to provide the Company with growth opportunities.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-05-08 Douglas Machine & Tool Co.

Cincinnati, Ohio, United States

Douglas Machine, based in Cincinnati, Ohio, was a leading manufacturer of industrial and aerospace gas turbine engine components. Widely considered to be the leading provider of drilling services to the turbine industry, Douglas Machine was named GE Power Systems' "Supplier of the Year" in 2002-2004. Its unique EDM process technology enables it to produce the lowest cost and highest quality precision components in the industry. An additional facility in Budapest, Hungary serves European customers.

Buy -
SELLER
DESCRIPTION

EEP is a Venture Capital investment firm that provides both dedication and passion on top of the financial investment itself. With more than 25 years of investment experience in life sciences, EEP provides deep sectorial knowledge and an established network. EEP was founded in 1999 and is based in London, England.


DEAL STATS #
Overall 2 of 5
Sector: Life Science M&A 2 of 4
Type: Add-on Acquisition M&A Deals 2 of 4
Country: France M&A 1 of 2
Year: 2006 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2002-01-01 PharmaKinetics

Baltimore, Maryland, United States

PharmaKinetics is a Contract Research Organization (“CRO”) providing pharmacology and bioanalysis services to the generic pharmaceutical industry.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-29 AGC Biologics

Bothell, Washington, Denmark

AGC Biologics is a global contract manufacturing and development (CDMO) company for biopharmaceuticals. AGC Biologics is based in Bothell, Washington.

Buy -